Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms

La Rosée P, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133:2465–77. https://doi.org/10.1182/blood.2018894618.

Article  CAS  PubMed  Google Scholar 

Scott RB, Robb-Smith A. Histiocytic medullary reticulosis. The Lancet. 1939;234:194–8.

Article  Google Scholar 

Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27:519–25. https://doi.org/10.1136/adc.27.136.519.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chinnici A, et al. Approaching hemophagocytic lymphohistiocytosis. Front Immunol. 2023;14:1210041. https://doi.org/10.3389/fimmu.2023.1210041.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stepp SE, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957–9. https://doi.org/10.1126/science.286.5446.1957.

Article  CAS  PubMed  Google Scholar 

Sayos J, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998;395:462–9. https://doi.org/10.1038/26683.

Article  CAS  PubMed  Google Scholar 

Nichols KE, et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 1998;95:13765–70. https://doi.org/10.1073/pnas.95.23.13765.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coffey AJ, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20:129–35. https://doi.org/10.1038/2424.

Article  CAS  PubMed  Google Scholar 

Barbosa MD, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature. 1996;382:262–5. https://doi.org/10.1038/382262a0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borgia RE, Gerstein M, Levy DM, Silverman ED, Hiraki LT. Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2018;70:616–24. https://doi.org/10.1002/art.40417.

Article  CAS  PubMed  Google Scholar 

García-Pavón S, Yamazaki-Nakashimada MA, Báez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol. 2017;39:445–51. https://doi.org/10.1097/mph.0000000000000872.

Article  PubMed  Google Scholar 

Arlet JB, et al. Reactive haemophagocytic syndrome in adult-onset Still’s disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65:1596–601. https://doi.org/10.1136/ard.2005.046904.

Article  PubMed  PubMed Central  Google Scholar 

Grom AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr. 1996;129:630–2. https://doi.org/10.1016/s0022-3476(96)70140-3.

Article  CAS  PubMed  Google Scholar 

Knauft J, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia. 2024;38:235–49. https://doi.org/10.1038/s41375-024-02135-8.

Article  PubMed  PubMed Central  Google Scholar 

West J, et al. 1-year survival in haemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003–2018. J Hematol Oncol. 2023;16:56. https://doi.org/10.1186/s13045-023-01434-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trottestam H, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118:4577–84. https://doi.org/10.1182/blood-2011-06-356261.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henter JI, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367–73. https://doi.org/10.1182/blood-2002-01-0172.

Article  CAS  PubMed  Google Scholar 

Locatelli F, et al. Emapalumab in children with primary hemophagocytic lymphohistiocytosis. N Engl J Med. 2020;382:1811–22. https://doi.org/10.1056/NEJMoa1911326.

Article  PubMed  Google Scholar 

Liu D, Zhao J. Cytokine release syndrome: grading, modeling, and new therapy. J Hematol Oncol. 2018;11:121. https://doi.org/10.1186/s13045-018-0653-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao Z, Li R, Meng L, Han Z, Hong Z. Macrophage, the potential key mediator in CAR-T related CRS. Exp Hematol Oncol. 2020;9:15. https://doi.org/10.1186/s40164-020-00171-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nguyen TTT, Kim YT, Jeong G, Jin M. Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective. Exp Mol Med. 2024;56:559–69. https://doi.org/10.1038/s12276-024-01182-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Saint Basile G, Ménasché G, Fischer A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol. 2010;10:568–79. https://doi.org/10.1038/nri2803.

Article  CAS  PubMed  Google Scholar 

Dieckmann NM, Frazer GL, Asano Y, Stinchcombe JC, Griffiths GM. The cytotoxic T lymphocyte immune synapse at a glance. J Cell Sci. 2016;129:2881–6. https://doi.org/10.1242/jcs.186205.

Article  CAS  PubMed  Google Scholar 

Stinchcombe JC, Bossi G, Booth S, Griffiths GM. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity. 2001;15:751–61. https://doi.org/10.1016/s1074-7613(01)00234-5.

Article  CAS  PubMed  Google Scholar 

Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol. 2006;6:940–52. https://doi.org/10.1038/nri1983.

Article  CAS  PubMed  Google Scholar 

Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135:1332–43. https://doi.org/10.1182/blood.2019000936.

Article  PubMed  PubMed Central  Google Scholar 

Jenkins MR, et al. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212:307–17. https://doi.org/10.1084/jem.20140964.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jessen B, et al. Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice. Front Immunol. 2013;4:448. https://doi.org/10.3389/fimmu.2013.00448.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif